This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this book Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marks, D. L. Articles by Cone, R. D. Search for Related Content PubMed PubMed Citation Articles by Marks, D. L. Articles by Cone, R. D.

Central Melanocortins and the Regulation of Weight During Acute and Chronic Disease

Daniel L. Marks^* and Roger D. Cone

^* Department of Pediatric Endocrinology, Oregon Health Sciences University, Portland, Oregon 97201
The Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201

ABSTRACT

Recent advances in our understanding of the regulation of body weight, appetite, and metabolic rate have highlighted the role of the adipose-derived hormone leptin and its receptor as fundamental modulators of these processes. Investigations of the neural targets for leptin action — as well as characterization of the agouti obesity syndrome — have, in turn, led to the discovery of fundamental neural pathways involved in the central regulation of energy homeostasis. In particular, the central melanocortin system has been shown to regulate appetite and metabolic rate in rodents; mutations in this system have been demonstrated to result in obesity in humans. Overall, the melanocortin system appears to function as a bidirectional rheostat in the regulation of energy intake and expenditure in rodents and potentially in humans. The first section of this chapter will focus on the development of our understanding of melanocortin physiology in the context of obesity. In particular, recent data regarding the interplay between melanocortin and neuropeptide Y (NPY) signaling at a cellular level will be discussed. The following section will discuss the hypothesis that melanocortin signaling plays a role in pathological weight loss and hypermetabolism observed in murine cachexia models. The potential role of this system in integrating a variety of anorexic and cachexic signals, as well as the potential for its pharmacological manipulation in the treatment of human cachexia, will be discussed.

This article has been cited by other articles:

				J. R. Klein The immune system as a regulator of thyroid hormone activity. Experimental Biology and Medicine, March 1, 2006; 231(3): 229 - 236. [Abstract] [Full Text] [PDF]

				S. O. Fetissov, J. Harro, M. Jaanisk, A. Jarv, I. Podar, J. Allik, I. Nilsson, P. Sakthivel, A. K. Lefvert, and T. Hokfelt Autoantibodies against neuropeptides are associated with psychological traits in eating disorders PNAS, October 11, 2005; 102(41): 14865 - 14870. [Abstract] [Full Text] [PDF]

				C. Fekete, P. S. Singru, S. Sarkar, W. M. Rand, and R. M. Lechan Ascending Brainstem Pathways Are Not Involved in Lipopolysaccharide-Induced Suppression of Thyrotropin-Releasing Hormone Gene Expression in the Hypothalamic Paraventricular Nucleus Endocrinology, March 1, 2005; 146(3): 1357 - 1363. [Abstract] [Full Text] [PDF]

				A. J. van der Lely, M. Tschop, M. L. Heiman, and E. Ghigo Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin Endocr. Rev., June 1, 2004; 25(3): 426 - 457. [Abstract] [Full Text] [PDF]

				J. F. Kelly, C. F. Elias, C. E. Lee, R. S. Ahima, R. J. Seeley, C. Bjorbaek, T. Oka, C. B. Saper, J. S. Flier, and J. K. Elmquist Ciliary Neurotrophic Factor and Leptin Induce Distinct Patterns of Immediate Early Gene Expression in the Brain Diabetes, April 1, 2004; 53(4): 911 - 920. [Abstract] [Full Text] [PDF]

				C. Bjorbaek and B. B. Kahn Leptin Signaling in the Central Nervous System and the Periphery Recent Prog. Horm. Res., January 1, 2004; 59(1): 305 - 331. [Abstract] [Full Text]

				J. M. Zigman and J. K. Elmquist Minireview: From Anorexia to Obesity--The Yin and Yang of Body Weight Control Endocrinology, September 1, 2003; 144(9): 3749 - 3756. [Abstract] [Full Text] [PDF]

				J. B. TATRO and P. S. SINHA The Central Melanocortin System and Fever Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 246 - 257. [Abstract] [Full Text] [PDF]

				D. L. MARKS and R. D. CONE The Role of the Melanocortin-3 Receptor in Cachexia Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 258 - 266. [Abstract] [Full Text] [PDF]

				J. M. Cerda-Reverter, A. Ringholm, H. B. Schioth, and R. E. Peter Molecular Cloning, Pharmacological Characterization, and Brain Mapping of the Melanocortin 4 Receptor in the Goldfish: Involvement in the Control of Food Intake Endocrinology, June 1, 2003; 144(6): 2336 - 2349. [Abstract] [Full Text] [PDF]

				B. Holst, C. E. Elling, and T. W. Schwartz Metal Ion-mediated Agonism and Agonist Enhancement in Melanocortin MC1 and MC4 Receptors J. Biol. Chem., November 27, 2002; 277(49): 47662 - 47670. [Abstract] [Full Text] [PDF]

				G. A. Bray The Underlying Basis for Obesity: Relationship to Cancer J. Nutr., November 1, 2002; 132(11): 3451S - 3455. [Abstract] [Full Text] [PDF]

				D. Hamerman Molecular-Based Therapeutic Approaches in Treatment of Anorexia of Aging and Cancer Cachexia J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2002; 57(8): M511 - 518. [Abstract] [Full Text] [PDF]